Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Vodafone Business Services launch 'dCare Smart'
Vodafone Business Services (VBS) collaborate with Diabetacare to launch dCare Smart, a device that helps people manage diabetes better. The device transmits blood sugar results to a secure Diabetacare server, where they are constantly monitored by diabetes specialist clinicians at the Diabetacare’s Diabetes Management Centre (DMC). dCare Smart is paired with the back-end clinical servers which connect directly to the electronic medical record system, wherein access is given to patients and their caregivers to keep them informed and better manage the condition.
- Read more about Scientists Target Kupffer Cell Protein CD68 to cure malaria
Which plays a crucial role in malaria infection, and may lead to potential new drug to fight the disease. The study is published in Journal of Experimental Medicine.
- Read more about Biocon’s novel ophthalmology molecule, QPI-1007, entered for clinical phase
Biocon’s novel drug pipeline which has an ophthalmology molecule, QPI-1007, is entering clinical trial phase. QPI-1007 is for ocular neuroprotection in NAION and acute angle closure glaucoma. In mid-December 2013, the company entered into a licensing and collaboration agreement for the development of a range of siRNA (small interfering RNA) based novel therapeutics with Quark Pharmaceuticals which was researching on QPI-1007.
- Read more about Scientists identify that memories can be lost and found
A team of scientists believe they have shown that memories are more robust than we thought and have identified the process in the brain, which could help rescue lost memories or bury bad memories, and pave the way for new drugs and treatment for people with memory problems.
- Read more about First interim results from Ebola vaccine efficacy trial suggest vaccine provides high protection against disease
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
- Read more about Getting to the bottom of ageing
The question of why we age is one of the most fascinating questions for humankind, but nothing close to a satisfactory answer has been found to date. Scientists at the Leibniz-Institut für Molekulare Pharmakologie in Berlin have now taken one step closer to providing an answer.
- Read more about USFDA reject approval of Sun Pharma’s novel anti-glaucoma eye drops
USFDA rejected Sun Pharma Advanced Research Company’s Application for its new anti-glaucoma eye drops. The product is to be manufactured at Sun Pharmaceutical Industries’ Halol facility. USFDA has indicated that a satisfactory resolution of the current good manufacturing practice (cGMP) deficiencies at this facility is a prerequisite for the final approval of Xelpros.
- Read more about Pharmexcil launch online services to accept submission for MDA, MAI claims
Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently launched online services to accept submission for Market Development Assistance (MDA) and Market Development Initiative (MDI) claims.This move is aimed at delivering not only hassle-free timely services to the members.
- Read more about Nutech Mediworld's human embryonic stem cell technology get Malaysian patent
Nutech Mediworld, the world’s only human embryonic stem cell therapy centre based in India, announced that its human embryonic stem cell (hESC) technology developed by Dr Geeta Shroff has received 66th patent in Malaysia for the treatment of various medical conditions.
The technology differentiates itself from other stem cell therapies in three major ways. Firstly, it has universal application, i.e. anyone and everyone can take these cells without the need for matching. Secondly, it is available in a ready to use form with a shelf life of 6 months & can be transported easily. Thus is not clinic based. Thirdly, it has an easy non-invasive delivery mechanism and can be administered in the simple form of an injection. Due to these qualities it has the potential to be made readily available in pharmacies across the world, much like insulin.

[adsense:336x280:8701650588]
- Read more about Novel way to cook rice by Percolating Technology Remove Inorganic Arsenic
The European Food Standards Authority has warned that people who eat a lot of rice, are exposed to worrying concentrations. Chronic exposure to inorganic arsenic has been linked to developmental problems, heart disease, diabetes, nervous system damage, and cancer. Researchers in Northern Ireland have now found a way to remove the inorganic arsenic by cooking rice the way coffee is brewed.